Snow Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Snow Capital Management's PFE Position: Q2 2021 in Review
Snow Capital Management increased its Pfizer (PFE) stake by 26% in Q2 2021, buying an estimated $2.02M and bringing the position to 250,171 shares worth $9.8M. The position accounts for 1.39% of the portfolio, ranked #28.
Snow Capital Management first reported a position in PFE in Q1 2018 and has held it in 3 quarters since. 2,733 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- Snow Capital Management held 250,171 shares of Pfizer worth $9.8M as of Q2 2021.
- Snow Capital Management bought 51,901 Pfizer shares in Q2 2021, an estimated $2.02M.
- Pfizer made up 1.39% of Snow Capital Management's portfolio in Q2 2021, its #28 holding.
- Snow Capital Management first reported a position in Pfizer in Q1 2018 and has held it in 3 quarters since.
- 2,733 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on Snow Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.